Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

NCT02169440 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease (PD)

Interventions

DRUG: BIA 9-1067
DRUG: Warfarin

Sponsor

Bial - Portela C S.A.